Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 130,270,192
  • Shares Outstanding, K 1,350,510
  • Annual Sales, $ 29,953 M
  • Annual Income, $ 3,104 M
  • 36-Month Beta 0.92
  • Price/Sales 4.37
  • Price/Cash Flow 14.33
  • Price/Book 2.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/18
See More
  • Average Estimate 1.14
  • Number of Estimates 13
  • High Estimate 1.16
  • Low Estimate 1.14
  • Prior Year 1.07
  • Growth Rate Est. (year over year) +6.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.00 +4.82%
on 08/21/18
97.76 -0.29%
on 09/20/18
+7.45 (+8.28%)
since 08/20/18
3-Month
83.61 +16.60%
on 07/02/18
97.76 -0.29%
on 09/20/18
+11.35 (+13.18%)
since 06/20/18
52-Week
76.41 +27.57%
on 03/23/18
97.76 -0.29%
on 09/20/18
+17.32 (+21.61%)
since 09/20/17

Most Recent Stories

More News
Medtronic To Acquire Mazor Robotics

Medtronic plc (NYSE: MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ: MZOR, TASE: MZOR.TA), a pioneer in the field of robotic guidance systems, today announced the companies have...

MZOR : 52.75 (+4.91%)
MDT : 97.48 (+1.06%)
Medtronic to Acquire Mazor Robotics

MDT : 97.48 (+1.06%)
Obesity Surgery Devices: Global Markets to 2024 Featuring Ethicon, Medtronic, Apollo Endosurgery, Reshape Lifesciences, Aspire Bariatrics, and more - ResearchAndMarkets.com

The "Obesity Surgery Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

APEN : 7.15 (+1.42%)
MDT : 97.48 (+1.06%)
Muscle Relaxant Drugs - Global Markets to 2024: Abbott Labs, Medtronic, Johnson & Johnson, Endo Pharma, and more are Profiled - ResearchAndMarkets.com

The "Muscle Relaxants Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

ABT : 68.79 (+0.42%)
JNJ : 141.98 (+1.08%)
MDT : 97.48 (+1.06%)
BIOMEDevice San Jose 2018 Brings Emerging Medical Technology to the Forefront

BIOMEDevice San Jose 2018, Silicon Valley's leading event for medtech professionals, today announced that it will feature over 20 hours of industry-specific educational content on emerging technologies...

MDT : 97.48 (+1.06%)
ISRG : 561.18 (+0.85%)
Medtronic (MDT) Up 0.9% Since Last Earnings Report: Can It Continue?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MDT : 97.48 (+1.06%)
Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

Medtronic Receives FDA Approval for Revised TAVR Labeling and Begins Investigational Study of Low Risk Patients with Bicuspid Valves

MDT : 97.48 (+1.06%)
Robbins Geller Rudman & Dowd LLP and Motley Rice LLC Announce Proposed Settlement in the Medtronic, Inc. Securities Litigation

The following statement is being issued by Robbins Geller Rudman & Dowd LLP and Motley Rice LLP regarding the Medtronic, Inc. Securities Litigation:

MDT : 97.48 (+1.06%)
Medtronic Recognized for Its Sustainability Leadership

Company Marks its Eleventh Consecutive Year on the North American Dow Jones Sustainability Index (DJSI)

MDT : 97.48 (+1.06%)
Global Balloon Catheters Market Forecasts 2018-2023 with Profiles of Key Players - Boston Scientific, Biomerics, B. Braun, Teleflex Medical, Medtronic, and A.V Medical

https://mma.prnewswire.com/media/732750/Research_and_Markets.jpg

BSX : 37.82 (+0.88%)
MDT : 97.48 (+1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade MDT with:

Business Summary

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders...

See More

Key Turning Points

2nd Resistance Point 98.30
1st Resistance Point 97.89
Last Price 97.48
1st Support Level 96.94
2nd Support Level 96.40

See More

52-Week High 97.76
Last Price 97.48
Fibonacci 61.8% 89.60
Fibonacci 50% 87.09
Fibonacci 38.2% 84.57
52-Week Low 76.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar